<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Viaderma Inc — News on 6ix</title>
<link>https://6ix.com/company/viaderma-inc</link>
<description>Latest news and press releases for Viaderma Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 16 Jul 2025 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/viaderma-inc" rel="self" type="application/rss+xml" />
<item>
<title>ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-posting-of-annual-report-and-ongoing-evaluation-of-public-status-in-response-to-market-changes</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-posting-of-annual-report-and-ongoing-evaluation-of-public-status-in-response-to-market-changes</guid>
<pubDate>Wed, 16 Jul 2025 12:00:00 GMT</pubDate>
<description>LOS ANGELES, July 16, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, announced today that its 2024 Annual Report has been posted to the company’s official website, www.viaderma.com. Due to the company’s current designation on the OTC Markets Expert Market, financial reports are not permitted to be posted directly to the OTC Markets platform. As part of its ongoing commitment to transparency, ViaDerma is making the Annual Report publicly acc</description>
</item>
<item>
<title>ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-inc-confirms-ongoing-operations-and-commitment-to-regulatory-compliance</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-inc-confirms-ongoing-operations-and-commitment-to-regulatory-compliance</guid>
<pubDate>Wed, 04 Jun 2025 12:30:00 GMT</pubDate>
<description>LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, today announced that it remains fully operational and is actively working to complete its overdue annual and quarterly financial reports. The company is not defunct and continues to pursue its business objectives. ViaDerma is currently exploring all strategic options to move the company forward in the most effective manner possible. About ViaDerma, Inc.ViaDerma, Inc. (OTC</description>
</item>
<item>
<title>ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-inc-strengthens-global-expansion-with-new-dubai-office-and-progress-towards-product-registration-in-india</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-inc-strengthens-global-expansion-with-new-dubai-office-and-progress-towards-product-registration-in-india</guid>
<pubDate>Tue, 21 Jan 2025 13:00:57 GMT</pubDate>
<description>ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India.</description>
</item>
<item>
<title>ViaDerma Announces Significant 2024 Achievements and International Expansion</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-significant-2024-achievements-and-international-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-significant-2024-achievements-and-international-expansion</guid>
<pubDate>Tue, 10 Dec 2024 13:00:54 GMT</pubDate>
<description>ViaDerma Announces Significant 2024 Achievements and International Expansion.</description>
</item>
<item>
<title>ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-inc-reports-strong-financial-results-for-q2-2024-achieving-positive-net-income-and-significant-cash-flow-growth</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-inc-reports-strong-financial-results-for-q2-2024-achieving-positive-net-income-and-significant-cash-flow-growth</guid>
<pubDate>Thu, 03 Oct 2024 12:02:54 GMT</pubDate>
<description>ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth.</description>
</item>
<item>
<title>ViaDerma Completes First Shipment of 500,000 Units to Nigeria</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-completes-first-shipment-of-500000-units-to-nigeria</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-completes-first-shipment-of-500000-units-to-nigeria</guid>
<pubDate>Tue, 10 Sep 2024 12:04:03 GMT</pubDate>
<description>ViaDerma Completes First Shipment of 500,000 Units to Nigeria.</description>
</item>
<item>
<title>ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-shipment-of-500000-units-of-its-flagship-product-to-nigeria</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-shipment-of-500000-units-of-its-flagship-product-to-nigeria</guid>
<pubDate>Tue, 13 Aug 2024 12:05:13 GMT</pubDate>
<description>ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria.</description>
</item>
<item>
<title>ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-finalizes-distribution-agreements-in-dubai-and-announces-six-new-key-hires</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-finalizes-distribution-agreements-in-dubai-and-announces-six-new-key-hires</guid>
<pubDate>Thu, 01 Aug 2024 12:02:54 GMT</pubDate>
<description>ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires.</description>
</item>
<item>
<title>ViaDerma Provides Highlights of Quarterly Financial Report</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-provides-highlights-of-quarterly-financial-report</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-provides-highlights-of-quarterly-financial-report</guid>
<pubDate>Thu, 06 Jun 2024 12:01:10 GMT</pubDate>
<description>ViaDerma Provides Highlights of Quarterly Financial Report.</description>
</item>
<item>
<title>ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-update-on-stability-testing-global-sales-distribution-national-licensing-nupelo-and-more</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-update-on-stability-testing-global-sales-distribution-national-licensing-nupelo-and-more</guid>
<pubDate>Tue, 24 Oct 2023 14:30:06 GMT</pubDate>
<description>ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More.</description>
</item>
<item>
<title>ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More </title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-updates-for-vitastem-global-sales-expansion-nupelo-fda-registration-status-and-more</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-updates-for-vitastem-global-sales-expansion-nupelo-fda-registration-status-and-more</guid>
<pubDate>Thu, 06 Jul 2023 12:04:16 GMT</pubDate>
<description>ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More.</description>
</item>
<item>
<title>ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-fda-registration-application-update-and-brand-name-for-new-hair-regrowth-product</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-fda-registration-application-update-and-brand-name-for-new-hair-regrowth-product</guid>
<pubDate>Thu, 16 Mar 2023 12:00:24 GMT</pubDate>
<description>ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product.</description>
</item>
<item>
<title>ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-intent-to-launch-a-new-minoxidil-hair-regrowth-product</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-intent-to-launch-a-new-minoxidil-hair-regrowth-product</guid>
<pubDate>Wed, 08 Mar 2023 13:00:12 GMT</pubDate>
<description>ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product.</description>
</item>
<item>
<title>ViaDerma Provides an Update on Current & Future Business Activities</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-provides-an-update-on-current-and-future-business-activities</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-provides-an-update-on-current-and-future-business-activities</guid>
<pubDate>Thu, 02 Mar 2023 13:01:06 GMT</pubDate>
<description>ViaDerma Provides an Update on Current & Future Business Activities.</description>
</item>
<item>
<title>ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-engages-intent-sciences-to-power-up-digital-marketing-and-brand-development</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-engages-intent-sciences-to-power-up-digital-marketing-and-brand-development</guid>
<pubDate>Thu, 12 Jan 2023 13:01:10 GMT</pubDate>
<description>ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development.</description>
</item>
<item>
<title>ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-successfully-completes-quality-control-testing-of-its-new-vitastem-products</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-successfully-completes-quality-control-testing-of-its-new-vitastem-products</guid>
<pubDate>Thu, 15 Sep 2022 09:01:13 GMT</pubDate>
<description>ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products.</description>
</item>
<item>
<title>ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-announces-the-implementation-of-internal-quality-control-measures-for-its-new-vitastem-products</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-announces-the-implementation-of-internal-quality-control-measures-for-its-new-vitastem-products</guid>
<pubDate>Wed, 22 Jun 2022 13:00:50 GMT</pubDate>
<description>ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products.</description>
</item>
<item>
<title>ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year</title>
<link>https://6ix.com/company/viaderma-inc/news/viadermas-2021-annual-report-shows-strong-revenue-growth-over-the-previous-year</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viadermas-2021-annual-report-shows-strong-revenue-growth-over-the-previous-year</guid>
<pubDate>Thu, 31 Mar 2022 09:01:40 GMT</pubDate>
<description>ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year.</description>
</item>
<item>
<title>ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-inc-set-to-launch-two-new-and-improved-versions-of-its-flagship-product-vitastem-and-vitastem-ultra</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-inc-set-to-launch-two-new-and-improved-versions-of-its-flagship-product-vitastem-and-vitastem-ultra</guid>
<pubDate>Mon, 04 Oct 2021 09:01:09 GMT</pubDate>
<description>ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra.</description>
</item>
<item>
<title>ViaDerma, Inc. Files Amended Financial Statements</title>
<link>https://6ix.com/company/viaderma-inc/news/viaderma-inc-files-amended-financial-statements</link>
<guid isPermaLink="true">https://6ix.com/company/viaderma-inc/news/viaderma-inc-files-amended-financial-statements</guid>
<pubDate>Tue, 24 Aug 2021 14:24:11 GMT</pubDate>
<description>ViaDerma, Inc. Files Amended Financial Statements.</description>
</item>
</channel>
</rss>